Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)
China · Delayed Price · Currency is CNY 6.68
+0.03 (0.45%)
Feb 13, 2026, 3:00 PM CST
Jiangsu Nanfang Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -202.28 | -190.67 | -147.42 | -14.65 | -22.76 | 98.07 |
Depreciation & Amortization | 50.44 | 50.44 | 54.67 | 41.61 | 29.04 | 20.31 |
Other Amortization | 4.62 | 4.62 | 2.31 | 2.7 | 1.59 | 1.31 |
Loss (Gain) From Sale of Assets | -0.26 | -0.26 | 2.9 | -0.02 | -0.05 | -0.02 |
Asset Writedown & Restructuring Costs | 38.87 | 38.87 | 35.55 | 0.05 | 2.48 | 16.09 |
Loss (Gain) From Sale of Investments | -8.22 | -8.22 | -9.29 | -8.59 | -7.65 | -10.04 |
Provision & Write-off of Bad Debts | -16.53 | -16.53 | 29.89 | 4.43 | 4.58 | 9.24 |
Other Operating Activities | 72.2 | 40.21 | 54.37 | 25.31 | 34.59 | 41.91 |
Change in Accounts Receivable | 56.23 | 56.23 | -23.24 | -33.77 | -16.84 | -46.67 |
Change in Inventory | 63.88 | 63.88 | -0.38 | -76.84 | -113.14 | -11.16 |
Change in Accounts Payable | 35.51 | 35.51 | 17.74 | 105.62 | 2.79 | 38.54 |
Change in Other Net Operating Assets | - | - | - | - | 10.97 | 0.6 |
Operating Cash Flow | 83.7 | 63.32 | 15.51 | 31.28 | -84.25 | 154.12 |
Operating Cash Flow Growth | -37.64% | 308.27% | -50.41% | - | - | 367.12% |
Capital Expenditures | -9.61 | -32.41 | -66.16 | -146.16 | -211.75 | -123.29 |
Sale of Property, Plant & Equipment | 0.42 | 0.42 | 0.94 | 0.07 | 0.09 | 0.05 |
Divestitures | - | - | - | - | - | -0.07 |
Investment in Securities | - | - | - | - | -20 | 40 |
Other Investing Activities | 7.54 | 6.85 | 48.87 | 96.7 | 6.28 | 7.1 |
Investing Cash Flow | -1.65 | -25.14 | -16.35 | -181.42 | -225.38 | -76.21 |
Short-Term Debt Issued | - | - | - | - | - | 544.9 |
Long-Term Debt Issued | - | 556.5 | 602.53 | 980.94 | 792.25 | - |
Total Debt Issued | 465.7 | 556.5 | 602.53 | 980.94 | 792.25 | 544.9 |
Short-Term Debt Repaid | - | - | - | - | - | -509.28 |
Long-Term Debt Repaid | - | -553.01 | -638.61 | -836.8 | -619.06 | - |
Total Debt Repaid | -542.13 | -553.01 | -638.61 | -836.8 | -619.06 | -509.28 |
Net Debt Issued (Repaid) | -76.43 | 3.49 | -36.08 | 144.14 | 173.18 | 35.62 |
Issuance of Common Stock | - | - | - | - | - | 39.46 |
Repurchase of Common Stock | - | - | - | - | -1.41 | - |
Common Dividends Paid | -19.05 | -27.08 | -21.63 | -18.6 | -47.09 | -15.83 |
Other Financing Activities | -37.05 | -18.6 | - | - | - | - |
Financing Cash Flow | -132.52 | -42.19 | -57.71 | 125.53 | 124.68 | 59.25 |
Foreign Exchange Rate Adjustments | 0.78 | 1.43 | -0.18 | -0.85 | -3.76 | -13.11 |
Net Cash Flow | -49.69 | -2.58 | -58.74 | -25.45 | -188.72 | 124.04 |
Free Cash Flow | 74.09 | 30.92 | -50.65 | -114.88 | -296.01 | 30.83 |
Free Cash Flow Growth | 5.35% | - | - | - | - | - |
Free Cash Flow Margin | 12.46% | 5.13% | -8.44% | -21.07% | -56.12% | 2.88% |
Free Cash Flow Per Share | 0.26 | 0.10 | -0.17 | -0.39 | -1.04 | 0.11 |
Cash Income Tax Paid | 2.02 | -3.8 | 11.03 | -49.62 | 2.61 | 24.17 |
Levered Free Cash Flow | 81.65 | -16.4 | -30.85 | -126.45 | -232.72 | -37.32 |
Unlevered Free Cash Flow | 104.67 | 0.12 | -16.36 | -113.83 | -225.34 | -32.58 |
Change in Working Capital | 144.86 | 144.86 | -7.48 | -19.56 | -126.07 | -22.74 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.